SCHEMBL9997141

SCHEMBL9997141

CCC/C=C(\CCC)C(OC(C)=O)OC(C)=O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 14/20 0.40
CYP2C19 P33261 11/20 0.40
CYP2C9 P11712 11/20 0.40
CYP2D6 P10635 6/20 0.40
CYP1A2 P05177 11/20 0.40
TSHR P16473 13/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
TBXA2R P21731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997143 1.00 CYP3A4 (0.40) CYP3A4CYP2C19CYP2C9CYP2D6CYP1A2
SCHEMBL9997544 0.89 LMNA (0.38) CYP3A4CYP2C19CYP2C9CYP2D6TSHR
SCHEMBL9997542 0.89 LMNA (0.38) CYP3A4CYP2C19CYP2C9CYP2D6TSHR
SCHEMBL9997620 0.87 EP300 (0.42) CYP2C19CYP2C9CYP1A2ALDH1A1MAPT
SCHEMBL9997623 0.87 EP300 (0.42) CYP2C19CYP2C9CYP1A2ALDH1A1MAPT
SCHEMBL9998538 0.86 TSHR (0.39) CYP1A2TSHRALDH1A1SMN1; SMN2MEN1
SCHEMBL9998537 0.86 TSHR (0.39) CYP1A2TSHRALDH1A1SMN1; SMN2MEN1
SCHEMBL9997227 0.86 TSHR (0.39) CYP3A4CYP2C19CYP2C9CYP2D6CYP1A2
SCHEMBL9997228 0.86 TSHR (0.39) CYP3A4CYP2C19CYP2C9CYP2D6CYP1A2
SCHEMBL9997653 0.86 EP300 (0.44) CYP3A4CYP2C19CYP2C9CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP3A4 36/4885CYP2C19 85/4885CYP2C9 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.